MAY 21, 2015 3:51 PM PDT

Cancer Drivers Live in Healthy Skin

WRITTEN BY: Ilene Schneider
When people reach late middle age, about a quarter of their skin cells carry cancer-driving mutations caused by exposure to sunlight. This phenomenon is not only normal; it may not even signal any reason for concern about tumor growth, according to a study published in the May 22 issue of Science and reported by Tina Hesman Saey in Science News (https://www.sciencenews.org/article/mutations-drive-cancer-lurk-healthy-skin).
Long exposure to sunlight can cause skin cancer, but the triggers may be found in normal cells too.
While researchers used to think that the types of mutations that lead to tumor growth were "rare and happened just before a cell becomes cancerous," a study of the eyelids of four people who do not have cancer demonstrates that such mutations "are staggeringly common in normal skin," according to Philip Jones, a clinical scientist at the University of Cambridge, the article explains. Jones's team procured 234 skin samples from four people ages 55 to 73 who had plastic surgery to correct droopy eyelids. After DNA sequencing, it was revealed that approximately 20 percent of the skin cells had mutations in the NOTCH1gene. According to the article in Science, that gene, when mutated, is "a driving force in some cancers, including skin cancers called squamous cell carcinomas."

Dr. Jones, who is a clinical doctor treating patients with cancer and also a scientist researching how the behavior of normal cells changes as they turn into cancer cells, is interested in tracking the fate of large numbers of cells and analyzing the data to understand the mathematical "rules" of cell behavior. "Normal cells follow a remarkably simple set of rules, which are only subtly distorted in cancer," he said.

"Once we know what the rules are, we can both predict cell fate and test how drugs and genes alter cell behavior far more efficiently than before. We are now starting to apply this work to human tissue samples and cancer cells to try to prevent cancers developing and improve cancer treatment," according to Dr. Jones in Health & Medicine News (http://hmnews.org/).

According to the National Cancer Insititute, skin cancer is the most common neoplasm in Caucasians in the United States "with a lifetime risk nearly equal to that of all other cancers combined." More than 800,000 people are likely to develop nonmelanoma skin cancer -- basal cell carcinoma (BCC) or squamous cell carcinoma (SCC)] -- annually in the United States. Sun exposure is the major environmental culprit. Although sun exposure is likely to begin early in life, the average patient with nonmelanoma skin cancer is about 60 years old. Researchers have established a connection between sun exposure and nonmelanoma skin cancer and have shown the sequence of events occurring between the time of initial sun exposure and subsequent skin cancer years later http://www.ncbi.nlm.nih.gov/pmc/articles/PMC33651/).
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAR 10, 2020
Cancer
MAR 10, 2020
Chemo more effective with Intralipid treatment
A study published recently in Scientific Reports suggests a novel technique to make chemotherapy more effective. Th ...
MAR 23, 2020
Cancer
MAR 23, 2020
An Alternative Use for Common Kidney Cancer Drug to Fight Against Epithelial Ovarian Cancer
Axitinib is a small molecule drug that inhibits VEGFR tyrosine kinases 1, 2, and 3. Shown previously to potentially prev ...
APR 18, 2020
Cancer
APR 18, 2020
A New Double Threat Against Skin Cancer
Skin cancer is one of the most common cancers in America.  One of the most aggressive forms of cancer is melanoma, ...
APR 17, 2020
Drug Discovery & Development
APR 17, 2020
Overcoming Multi-Drug Resistance in Cancer
Resistance to chemotherapeutic use in caner patients is something that is inevitable. Continued resistance to these drug ...
APR 27, 2020
Cancer
APR 27, 2020
The Tumor Suppressor and its Regulator: An Indirect Oncogene
Oncogenes, mutations in genes that promote cancer growth, have long been easy targets for cancer research due to the dir ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Drug Targets Hard To Treat Uterine Cancer
A clinical trial was deemed successful when evaluating a therapeutic for a hard-to-treat form of uterine cancer. The dru ...
Loading Comments...